Repurposing Chlorpromazine as add-on in the adjuvant phase of first-line glioblastoma therapeutic protocol in patients carrying hypo-/un-methylated MGMT gene promoter: RACTAC, a Phase II multicenter single arm clinical trial https://www.medrxiv.org/content/10.1101/2023.02.21.23286088